The economy already prices the consequences of human life expectancy. It just does not have a market for the expectation itself.
LIX is designed to add that missing market.
Medicine changes. Demographics change. Expectations change.A model tells you what you assume. A market can show what participants are pricing now.
LIX is designed to add a live, market-informed view to an economy that already makes enormous decisions around human life expectancy.
Start with the businesses, not the exchange.
Long-duration businesses make promises today that may not be fully resolved for decades. An annuity writer decides how much lifetime income it can promise. A life insurer decides what premium supports a future death benefit. A pension estimates how long retirement benefits may continue. A health insurer forecasts future medical costs. Government programs plan for populations whose health and age profiles change over time.
Those decisions begin with data and models, but they do not end there. The assumptions flow into pricing, reserves, capital, investment strategy, treasury, reinsurance, accounting, finance, audit, governance and regulatory work. A change in the view of human life expectancy can therefore change the economics of an entire book of business.
Today, the views are mostly private.
Every major institution can build its own estimate. That is useful and necessary. But an internal model answers a different question from a market. It tells a company what its own assumptions imply. It does not show what a broad group of institutions and investors are willing to price when real capital is at risk.
Markets do this elsewhere every day. They aggregate disagreement. Banks make markets. Natural risk holders seek protection. Investors and speculators take views. Asset managers allocate capital. Trading converts all of that disagreement into an observable price.
LIX brings that process to human life expectancy.
LIX is being built as a marketplace where pensions, insurers, reinsurers, banks, money managers, hedge funds, traders and other investors can trade expectations about human life expectancy. Some participants may come to reduce risk. Others may come to provide liquidity or because their research gives them a different view. Their interaction creates price discovery.
The resulting price is not a medical forecast and it is not a declaration of how long any individual will live. It is a market-implied view of expectations. That distinction is important: LIX adds information to existing models rather than asking institutions to abandon them.
Once a price exists, the market can serve the wider economy.
An insurer can compare its internal assumption with the market. A pension can observe whether expectations are moving. A finance team can use market information in valuation and planning discussions. A risk team can investigate whether selected exposure can be transferred. An asset manager can research a new market signal. A health or pharmaceutical company can observe how broader survival expectations respond as medicine and demographics change.
This is the broader LIX thesis: the value of the market is not limited to the people who trade. The market can create a common information layer for industries that already make decisions around human life expectancy.